Geral
CoronaVac use in children and adolescents in Brazil rejected
Brazil’s drug regulator Anvisa rejected the request by Butantan Institute for the use of the CoronaVac vaccine in children and adolescents aged three through 17. At an extraordinary Wednesday (Aug. 18) meeting, agency directors argued the data submitted by Butantan are not enough for a conclusion on the shot’s efficiency and safety in this age […]


